All serum samples were able to neutralize the viruses but were about two-thirds weaker against the B1351 spike protein. However, the authors said that because the vaccines also produce other types of immune responses, such as from T cells, they may be more effective in real life than in the lab.
Pfizer, Moderna vaccines may be less effective against B1351 variant | CIDRAP (umn.edu)